New Study: Patients, Employers and Taxpayers Could Save Significantly if Barriers to Biosimilars Removed Case Study: Increasing Use of Infliximab Biosimilar Could Lower Costs Up to $465 Million Annually...
Patients could save time and money if federal law is reformed to allow pharmacists to administer all CDC recommended vaccines, a new study released today by the Pacific Research Institute found. Click here to download a copy of the study. “Adult vaccines can improve people’s health, but...
As the political drumbeat for single-payer health care rises in Sacramento, other states around the country, and in Washington, DC, PRI’s Sally Pipes today released a new book that makes the case for why single-payer health care would be a disaster for all Americans, The...
President Trump recently “slammed” socialized medicine on Twitter. He was referring to a massive "NHS in Crisis: Fix It Now" protest that occurred on Feb. 3 in London. As the British might say, the president's analysis is "spot on." The United Kingdom's single-payer system is in turmoil. It'd be...